This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jinlei Zhu: Innovator in Pharmaceutical Chemistry
Introduction
Jinlei Zhu is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective BCL-2 inhibitors. His work is crucial in the fight against cancers related to anti-apoptotic proteins.
Latest Patents
Jinlei Zhu holds a patent for a "Crystal of trifluoromethyl/chloro disubstituted sulfonamide selective BCL-2 inhibitor." This patent describes a crystal of a compound of formula I, detailing a preparation method and its use in preventing and treating diseases associated with the BCL-2 protein, including various cancers. He has 1 patent to his name.
Career Highlights
Zhu is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His research focuses on developing effective treatments that target specific cancer pathways.
Collaborations
Jinlei Zhu has worked alongside notable colleagues, including Bin Wang and Yanlong Liu. Their collaborative efforts enhance the research and development capabilities within their organization.
Conclusion
Jinlei Zhu's contributions to pharmaceutical chemistry and his innovative patent work exemplify the importance of research in combating cancer. His ongoing efforts in this field are vital for advancing treatment options and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile